Psychosis with Coexisting Substance Misuse
RCPsych Publications
978-1-908020-30-7 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Around
40% of people experiencing psychosis also misuse substances at some point in
their lives, which can lead to serious health and social problems for the
person and complicate their treatment.
This
new guideline covers the assessment and management of adults and young people
(aged 14 years and older) who have a clinical diagnosis of psychosis
(schizophrenia, bipolar disorder or other affective psychosis) and coexisting
substance misuse (harmful use of any psychotropic substance including alcohol
and legal or illicit drugs).
Although
separate NICE guidelines have been
developed for the management of schizophrenia, bipolar disorder and drug and
alcohol misuse, the importance of this new guideline on psychosis and substance
misuse is in offering advice on how to integrate treatment for people with these
commonly coexisting conditions.
The
guideline includes comprehensive reviews of assessment, care pathways and
service delivery models, psychological and pharmacological interventions for
both conditions, and treatment and services for young people.
The National Collaborating Centre for Mental Health (NCCMH) was established in 2001 by the UK-based National Institute for Health and Clinical Excellence (NICE) to develop guidance on the appropriate treatment and care of people with mental health problems and then write the clinical guidelines. The NCCMH is a partnership between the Royal College of Psychiatrists and the British Psychological Society.
Contents
Preface
Psychosis with coexisting substance misuse
Method used to develop this guideline
Experience of care
Assessment and care pathways
Service delivery models
Psychological and psychosocial interventions
Pharmacological and physical interventions
Young people with psychosis and coexisting substance misuse
Summary of recommendations
Appendices
References
Abbreviations
Erscheint lt. Verlag | 1.11.2011 |
---|---|
Reihe/Serie | NICE Guidelines |
Verlagsort | London |
Sprache | englisch |
Maße | 170 x 240 mm |
Gewicht | 578 g |
Themenwelt | Geisteswissenschaften ► Psychologie ► Psychosen |
Medizin / Pharmazie ► Gesundheitswesen | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Suchtkrankheiten | |
ISBN-10 | 1-908020-30-X / 190802030X |
ISBN-13 | 978-1-908020-30-7 / 9781908020307 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |